These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 3132032)
41. Effect of exercise on ventricular response to atrial fibrillation in Wolff-Parkinson-White syndrome. Crick JC; Davies DW; Holt P; Curry PV; Sowton E Br Heart J; 1985 Jul; 54(1):80-5. PubMed ID: 4015920 [TBL] [Abstract][Full Text] [Related]
42. Initiation of atrial fibrillation by spontaneous ventricular premature beats in concealed Wolff-Parkinson-White syndrome. Shen EN; Sung RJ Am Heart J; 1982 May; 103(5):911-2. PubMed ID: 7072595 [No Abstract] [Full Text] [Related]
43. [Severe arrhythmia in Wolff-Parkinson-White syndrome]. Márquez-Montes J; Esteve Alderete JJ; Rufilanchas JJ; Benezet JM; Lorenzo AC; Lezáun R; de Artaza M Rev Esp Cardiol; 1980; 33(3):217-25. PubMed ID: 7422987 [No Abstract] [Full Text] [Related]
44. Supernormal conduction in the anomalous bundles of the Wolff-Parkinson-White syndrome: an overlooked electrophysiologic property with potential clinical implications. Chiale PA; Albino E; Garro HA; Selva H; Levi RJ; Sánchez RA; Elizari MV; Alvarez CB J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):181-91. PubMed ID: 17875945 [TBL] [Abstract][Full Text] [Related]
45. [Contraindications to the use of digitalis in atrial fibrillation in the course of Wolff-Parkinson-White syndrome]. Bracchetti D; Binetti G; D'Osualdo F; Magnani B Boll Soc Ital Cardiol; 1974; 19(2):181-6. PubMed ID: 4462802 [No Abstract] [Full Text] [Related]
46. Atrial fibrillation and the Wolff-Parkinson-White syndrome. Alimurung BN; Robinson PH; Clements SD South Med J; 1980 Jun; 73(6):806-8. PubMed ID: 7394619 [No Abstract] [Full Text] [Related]
47. [Reentrant tachycardia and atrial fibrillation in Wolff-Parkinson-White syndrome. V. Conversion of reentrant tachycardia into atrial fibrillation]. Musiał WJ Kardiol Pol; 1987; 30(6):361-7. PubMed ID: 3669487 [No Abstract] [Full Text] [Related]
48. Mechanisms determining the ventricular rate in wolff-parkinson-white arrhythmias. Castellanos A; Levy S; Befeler B; Myerburg RJ Adv Cardiol; 1975; 14():221-32. PubMed ID: 1136885 [TBL] [Abstract][Full Text] [Related]
49. Onset of atrial fibrillation during antidromic tachycardia: association with sudden cardiac arrest and ventricular fibrillation in a patient with Wolff-Parkinson-White syndrome. Cosio FG; Benson DW; Anderson RW; Hession WT; Pritzker MR; Kriett JM; Benditt DG Am J Cardiol; 1982 Aug; 50(2):353-9. PubMed ID: 7102563 [TBL] [Abstract][Full Text] [Related]
50. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. Klein GJ; Bashore TM; Sellers TD; Pritchett EL; Smith WM; Gallagher JJ N Engl J Med; 1979 Nov; 301(20):1080-5. PubMed ID: 492252 [TBL] [Abstract][Full Text] [Related]
51. [Wolff-Parkinson-White syndrome and sudden death]. Castillo-Fenoy A; Goupil A; Offenstadt G; Nguyen GK Ann Med Interne (Paris); 1973 Dec; 124(12):871-5. PubMed ID: 4791383 [No Abstract] [Full Text] [Related]
52. Precipitation of cardiac arrest by verapamil in patients with Wolff-Parkinson-White syndrome. McGovern B; Garan H; Ruskin JN Ann Intern Med; 1986 Jun; 104(6):791-4. PubMed ID: 3706931 [TBL] [Abstract][Full Text] [Related]
53. [Pharmacologic treatment of atrial fibrillation in patients with Wolff-Parkinson-White syndrome]. Banasiak W Wiad Lek; 1992 Oct; 45(19-20):770-4. PubMed ID: 1296383 [No Abstract] [Full Text] [Related]
54. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias. Hohnloser SH; Zabel M Am J Cardiol; 1992 Aug; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287 [TBL] [Abstract][Full Text] [Related]
55. Initiation of atrial fibrillation in the Wolff-Parkinson-White syndrome: the importance of the accessory pathway. Wathen M; Natale A; Wolfe K; Yee R; Klein G Am Heart J; 1993 Mar; 125(3):753-9. PubMed ID: 8438704 [TBL] [Abstract][Full Text] [Related]
56. Tachyarrhythmias in Wolff-Parkinson-White syndrome. Hwang YS Taiwan Yi Xue Hui Za Zhi; 1980 Dec; 79(12):1129-43. PubMed ID: 6943293 [No Abstract] [Full Text] [Related]
57. [Genesis of auricular fibrillation in the Wolff-Parkinson-White syndrome]. Gressard A; Atallah G; Chatelain MT; Touboul P Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1277-82. PubMed ID: 6797365 [TBL] [Abstract][Full Text] [Related]
58. Effects of flecainide on electrophysiological properties of accessory pathways in the Wolff-Parkinson-White syndrome. Neuss H; Buss J; Schlepper M; Berthold R; Mitrović V; Krämer A; Musial WJ Eur Heart J; 1983 May; 4(5):347-53. PubMed ID: 6617681 [TBL] [Abstract][Full Text] [Related]
59. Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway. Centurión OA; Shimizu A; Isomoto S; Konoe A Europace; 2008 Mar; 10(3):294-302. PubMed ID: 18308751 [TBL] [Abstract][Full Text] [Related]